Trial intelligence / Profile preview

Unspecified Phase 1-2 Antitumor Agent Trial (Japan)

jRCT2080223668Phase 2Completed

Start
Oct 2017
01

Overview

Phase 2 trial. Started Oct 2017; status: completed.

Beyond the preview

Go deeper on jRCT2080223668.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080223668.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call